Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$1.49B |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$423M |
| 3 |
SLB Ltd
SLB
|
+$408M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$340M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.59B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$464M |
| 3 |
Citigroup
C
|
+$340M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
451
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.69M | ﹤0.01% |
393,266
-7,249
| -2% | -$46K |
|
452
Quanex
NX
$959M
| $2.65M | ﹤0.01% |
152,132
+1,999
| +1% | +$38.9K |
|
453
Nike
NKE
$61.6B
| $2.63M | ﹤0.01% |
39,559
-139
| -0.4% | -$9.17K |
|
454
iShares Global Healthcare ETF
IXJ
$4.08B
| $2.59M | ﹤0.01% |
46,444
-681,418
| -94% | -$39.2M |
|
|
ARRY
455
DELISTED
Array Biopharma Inc
ARRY
| $2.58M | ﹤0.01% |
158,223
-3,210
| -2% | -$51.4K |
|
|
CLVS
456
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.53M | ﹤0.01% |
47,961
| – | – |
|
|
CSFL
457
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $2.47M | ﹤0.01% |
93,257
+1,399
| +2% | +$37.5K |
|
458
Icon
ICLR
$12.1B
| $2.47M | ﹤0.01% |
20,916
-4,200
| -17% | -$482K |
|
|
ICPT
459
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.45M | ﹤0.01% |
39,752
-100
| -0.3% | -$6.03K |
|
|
LMNX
460
DELISTED
Luminex Corp
LMNX
| $2.36M | ﹤0.01% |
111,939
+246
| +0.2% | +$5.03K |
|
|
PRAH
461
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.35M | ﹤0.01% |
28,380
-5,170
| -15% | -$459K |
|
462
PNC Financial Services
PNC
$101B
| $2.33M | ﹤0.01% |
15,382
-7,618
| -33% | -$1.18M |
|
463
Southside Bancshares
SBSI
$976M
| $2.28M | ﹤0.01% |
65,707
-691
| -1% | -$24K |
|
|
PGNX
464
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.27M | ﹤0.01% |
303,692
| – | – |
|
465
CF Industries
CF
$18.1B
| $2.25M | ﹤0.01% |
59,727
-2,429
| -4% | -$98.9K |
|
466
Knowles
KN
$3.45B
| $2.24M | ﹤0.01% |
177,698
-12,025
| -6% | -$175K |
|
|
MNTA
467
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.21M | ﹤0.01% |
121,507
-3,000
| -2% | -$50K |
|
468
Booking.com
BKNG
$151B
| $2.15M | ﹤0.01% |
25,850
-1,600
| -6% | -$126K |
|
469
Petrobras Class A
PBR.A
$107B
| $2.13M | ﹤0.01% |
164,202
| – | – |
|
470
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7B
| $2.04M | ﹤0.01% |
79,676
-2,028
| -2% | -$52K |
|
471
Travere Therapeutics
TVTX
$5.21B
| $1.97M | ﹤0.01% |
87,905
| – | – |
|
472
VanEck Vietnam ETF
VNM
$510M
| $1.96M | ﹤0.01% |
100,100
| – | – |
|
473
Lantheus
LNTH
$6.58B
| $1.91M | ﹤0.01% |
119,793
+1,820
| +2% | +$35.5K |
|
474
B&G Foods
BGS
$289M
| $1.88M | ﹤0.01% |
79,119
+1,465
| +2% | +$44.8K |
|
475
Entravision Communication
EVC
$1.07B
| $1.86M | ﹤0.01% |
394,803
+7,551
| +2% | +$48.8K |
|
Similar funds
Ken Fisher's Q1 2018 Portfolio in Review
As of Q1 2018, Ken Fisher held 991 positions worth $75.4B, down 1.5% from $76.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q1 2018 filing shows 69 new, 261 increased, 401 reduced and 162 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B. The largest sale was Barclays ETN+ FI Enhanced Global High Yield ETN, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q1 2018 buy was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B.
- Ken Fisher added most to SLB Ltd in Q1 2018, an estimated $408M increase.
- Ken Fisher's biggest Q1 2018 reduction was Barclays ETN+ FI Enhanced Global High Yield ETN, cutting an estimated $1.59B.
- Ken Fisher fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $123M.
- Ken Fisher's ten largest holdings make up 26% of its $75.4B portfolio in Q1 2018.
- Ken Fisher opened 69 new positions and closed 162 in Q1 2018.
- Ken Fisher's portfolio value fell 1.5% quarter-over-quarter to $75.4B.
Based on Fisher Asset Management's 13F filing for Q1 2018, filed 19 Apr 2018.